Trial intelligence / Profile preview

Ibutilide versus amiodarone for recent-onset atrial fibrillation or atrial flutter after coronary artery bypass grafting

ChiCTR-TRC-10001157Phase 4Completed

Sponsor
Changhai Hospital, Second Military Medical University
Start
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of ibutilide and amiodarone in Atrial fibrillation (AFib) and atrial flutter (AFL) (3 arms), sponsored by Changhai Hospital, Second Military Medical University. Primary endpoints: Torsades de pointes and Conversion rate. Started Oct 2010; status: completed.

02

Drugs

ibutilideamiodarone
03

Conditions

Atrial fibrillation (AFib)atrial flutter (AFL)

Beyond the preview

Go deeper on ChiCTR-TRC-10001157.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-10001157.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call